Sutton P, Danon S J, Walker M, Thompson L J, Wilson J, Kosaka T, Lee A
School of Microbiology and Immunology, University of New South Wales, Sydney, NSW 2052, Australia.
Gut. 2001 Oct;49(4):467-73. doi: 10.1136/gut.49.4.467.
Helicobacter pylori is a major cause of peptic ulcers and gastric cancer. Vaccine development is progressing but there is concern that immunisation may exacerbate Helicobacter induced gastritis: prophylactic immunisation followed by challenge with H felis or H pylori can induce a more severe gastritis in mice than seen with infection alone. The aim of this study was to investigate the relationship between immunity to Helicobacter infection and post-immunisation gastritis.
(1) C57BL/6 mice were prophylactically immunised before challenge with either H felis or H pylori. Histopathology and colonisation were assessed one month post-challenge. (2) C57BL/6 mice were prophylactically immunised against H felis infection and gastritis assessed up to 18 months post-challenge.
Prophylactic immunisation induced a reduction in bacterial colonisation following H felis challenge which was associated with increased severity of active gastritis with neutrophil infiltration and atrophy. However, immunised mice challenged with H pylori SS1 had little evidence of pathology. Long term follow up showed that post-immunisation gastritis was evident at three months. However, from six months onwards, although immunised/challenged mice still developed gastritis, there was no significant difference between inflammation in these mice and infected controls. Post-immunisation gastritis was not associated with the serum antibody response. Immunisation prevented the formation of secondary lymphoid aggregates in the gastric tissue.
The H felis mouse model of post-immunisation gastritis is the most extreme example of this type of pathology. We have shown in this model that post-immunisation gastritis is a transient event which does not produce long term exacerbation of pathology.
幽门螺杆菌是消化性溃疡和胃癌的主要病因。疫苗研发正在推进,但人们担心免疫接种可能会加重幽门螺杆菌引起的胃炎:在对小鼠进行预防性免疫接种后,再用猫螺杆菌或幽门螺杆菌进行攻击,会诱导出比单纯感染更严重的胃炎。本研究的目的是调查幽门螺杆菌感染免疫力与免疫接种后胃炎之间的关系。
(1)在对C57BL/6小鼠用猫螺杆菌或幽门螺杆菌进行攻击之前进行预防性免疫接种。在攻击后1个月评估组织病理学和细菌定植情况。(2)对C57BL/6小鼠进行预防性免疫接种以预防猫螺杆菌感染,并在攻击后长达18个月评估胃炎情况。
预防性免疫接种导致猫螺杆菌攻击后细菌定植减少,这与伴有中性粒细胞浸润和萎缩的活动性胃炎严重程度增加有关。然而,用幽门螺杆菌SS1攻击的免疫小鼠几乎没有病理证据。长期随访表明,免疫接种后3个月胃炎明显。然而,从6个月起,尽管免疫/攻击小鼠仍会发生胃炎,但这些小鼠的炎症与感染对照组之间没有显著差异。免疫接种后胃炎与血清抗体反应无关。免疫接种可防止胃组织中次级淋巴滤泡的形成。
免疫接种后胃炎的猫螺杆菌小鼠模型是这类病理的最极端例子。我们在这个模型中表明,免疫接种后胃炎是一个短暂事件,不会导致病理的长期加重。